San Francisco AIDS Foundation
HAART Chart: Approved Antiretroviral Drugs
Winter 2007
| Generic (Common) Name | Brand Name | Company | Year Approved |
| Protease Inhibitors (PIs) |
| amprenavir | Agenerase | GlaxoSmithKline | 1999; discontinued 2004 |
| atazanavir | Reyataz | Bristol-Myers Squibb | 2003 |
| darunavir (TMC114) | Prezista | Tibotec | 2006 |
| fosamprenavir | Lexiva (U.S.); Telzir (Europe) | GlaxoSmithKline | 2003 |
| indinavir | Crixivan | Merck | 1996 |
| lopinavir/ritonavir | Kaletra | Abbott | 2000; Meltrex formulation 2005 |
| nelfinavir | Viracept | Pfizer | 1997 |
| ritonavir | Norvir | Abbott | 1996 |
| saquinavir | Invirase (hard-gel)
Fortovase (soft-gel) | Roche | 1995
1997; withdrawn 2005 |
| tipranavir | Aptivus | Boehringer Ingelheim | 2005 |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) |
| abacavir | Ziagen | GlaxoSmithKline | 1998 |
| didanosine (ddI) | Videx | Bristol-Myers Squibb | 1989; extended release Videx EC 2000 |
| emtricitabine (FTC) | Emtriva | Gilead | 2003 |
| lamivudine (3TC) | Epivir | GlaxoSmithKline | 1995 |
| stavudine (d4T) | Zerit | Bristol-Myers Squibb | 1994 |
| tenofovir DF | Viread | Gilead | 2002 |
| zalcitabine (ddC) | Hivid | Roche | 1992; withdrawn 2005 |
| zidovudine (AZT) | Retrovir | GlaxoSmithKline | 1987 |
| Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) |
| delavirdine | Rescriptor | Pfizer | 1997 |
| efavirenz | Sustiva (U.S.); Stocrin (elsewhere) | Bristol-Myers Squibb | 1998 |
| nevirapine | Viramune | Boehringer Ingelheim | 1996 |
| Entry/Fusion Inhibitors |
| enfuvirtide (T-20) | Fuzeon | Trimeris | 2003 |
| Fixed-Dose Combinations |
| lamivudine/abacavir (NRTI) | Epzicom (U.S.); Kivexa (Europe) | GlaxoSmithKline | 2004 |
| tenofovir/emtricitabine (NRTI) | Truvada | Gilead | 2004 |
tenofovir/emtricitabine/
efavirenz (NRTI/NNRTI) | Atripla | Gilead/Bristol-Myers Squibb | 2006 |
| zidovudine/lamivudine (NRTI) | Combivir | GlaxoSmithKline | 1997 |
| zidovudine/lamivudine/abacavir (NRTI) | Trizivir | GlaxoSmithKline | 2000 |
This article was provided by
San Francisco AIDS Foundation.
It is a part of the publication Bulletin of Experimental Treatments for AIDS.
